Clinical trial Recruiting at 5 sites Observational Ages 65 and up

Factors linked to longer hospital stays after ERCP in older adults

Official title: Factors Associated With Prolonged Hospital Stay in Elderly Patients Undergoing Endoscopic Retrograde Cholangiopancreatography: A Prospective, Multicenter Cohort Study

Run by Air Force Military Medical University, China · NCT07568626 · Data updated 2026-11-12

This project will see which health and aging-related factors are linked to longer hospital stays after ERCP in people 65 and older.

Quick facts

Study typeObservational
Ages65 Years and up
SexAll
Enrollment504 (estimated)
SponsorAir Force Military Medical University, China
Academic / other
Locations5 sites (Xiamen, Fujian and 4 other locations)
StatusRecruiting
StartedFebruary 15, 2026
Main results expectedJanuary 1, 2027
Study endsJanuary 1, 2027
Registry record updatedJuly 14, 2026
Trial IDNCT07568626 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

People aged 65 or older who are scheduled to undergo ERCP, can give informed consent, and do not have severe cognitive or hearing impairment, hemodynamic instability, or suspected gastrointestinal perforation.

Probably not a fit

People younger than 65, those unable to provide consent, pregnant or lactating women, and patients with severe cognitive or hearing deficits, hemodynamic instability, or known/suspected GI perforation are not expected to benefit from participating.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study will enroll patients aged 65 and older who are scheduled for ERCP at participating hospitals in Xi'an, China and collect clinical, procedural, and aging-related data. Investigators will record postoperative adverse events (such as pancreatitis, bleeding, and perforation), length of stay, comorbidities, frailty, functional reserve, and cognitive and psychological measures. The goal is to identify which factors predict prolonged hospitalization after ERCP while reducing selection bias seen in prior retrospective work. Findings will be used to inform risk stratification and peri-procedural care for older adults undergoing ERCP.

Why it matters

Potential benefit: If successful, the results could help doctors identify older patients at higher risk for ERCP complications and prolonged stays so care can be tailored to reduce complications and shorten hospitalizations.

How similar studies have gone: Previous retrospective studies have suggested older age is linked to more ERCP complications and longer hospital stays, but comprehensive analyses that include frailty and cognitive measures are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patient age ≥ 65 years
2. Scheduled to undergo ERCP procedure

Exclusion Criteria:

1. Severe cognitive dysfunction
2. Severe hearing impairment
3. Known or suspected gastrointestinal perforation
4. Hemodynamic instability
5. Pregnant or lactating women
6. Unable to sign the informed consent form

Where it's running

  • Xiamen Hong'ai Hospital
    Xiamen, Fujian, China
    Recruiting
  • Xijing Hospital of Digestive Diseases
    Xi'an, Shaanxi, China
    Recruiting
  • The Second Affiliated Hospital of Air Force Military Medical University
    Xi'an, Shaanxi, China
    Recruiting
  • Department of Gastroenterology, 986 Hospital of Xijing Hospital, Fourth MilitaryMedical University
    Xi'an, Shaanxi, China
    Recruiting
  • Xi'an Honghui Hospital
    Xi'an, Shaanxi, China
    Recruiting

Study contacts

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.